Dr David L. Cooper
Dr Cooper was educated at Westminister College, New Wilmington, PA, Florida State University- Division of Biochemistry and the University of Florida-School of Medicine. Dr Cooper has a 25 year C-level management career spanning start-ups to Fortune 500 companies in biotechnology, informatics, diagnostics and pharmaceuticals. While Professor of Molecular Pathology at Duke and UPMC Dr Cooper’s research focused on defining the various isoforms and role of CD44 in tumour metastasis. He has authored more than 100 manuscripts including publications in Nature Medicine, the Proceedings of the National Academy of Science and the Journal of Cell Biology. Dr Copper consults widely in the pharmaceutical, diagnostic and healthcare industries and holds various board seats including industry relevant Acreage Holdings and the American Cannabinoid Clinics.
Dr Kaiyo Nedd
Dr Nedd has been a practising medical doctor for over 20 years in Vancouver B.C. He was educated at the University of British Columbia and MD. Howard University and the College of Medicine Washington D.C before undertaking emergency medicine rotation training at Harvard University Brigham and Women’s Hospital and family practice residency training at Vancouver, St Paul’s Hospital, completing the same in 2002. Since 2002 Dr Nedd has acted as medical director of West End Medical Centre in Vancouver British Columbia, which has provided broad patient exposure as well as Dr Nedd’s involvement in several clinical trials and regular participation in pharmaceutical company advisory boards. In recent years Dr Nedd’s focus has been on chronic pain and mental health and he has had deep clinical experience with the use of Cannabinoids and in the management of these conditions and continues to keep abreast of ongoing clinical research.